Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect.
Warburg effect
gluconeogenesis
glycolysis
hepatocellular carcinoma
tumor microenvironment
Journal
Cancer management and research
ISSN: 1179-1322
Titre abrégé: Cancer Manag Res
Pays: New Zealand
ID NLM: 101512700
Informations de publication
Date de publication:
2020
2020
Historique:
received:
14
04
2020
accepted:
30
06
2020
entrez:
9
8
2020
pubmed:
9
8
2020
medline:
9
8
2020
Statut:
epublish
Résumé
Hepatocellular carcinoma (HCC) is a tumor that exhibits glucometabolic reprogramming, with a high incidence and poor prognosis. Usually, HCC is not discovered until an advanced stage. Sorafenib is almost the only drug that is effective at treating advanced HCC, and promising metabolism-related therapeutic targets of HCC are urgently needed. The "Warburg effect" illustrates that tumor cells tend to choose aerobic glycolysis over oxidative phosphorylation (OXPHOS), which is closely related to the features of the tumor microenvironment (TME). The HCC microenvironment consists of hypoxia, acidosis and immune suppression, and contributes to tumor glycolysis. In turn, the glycolysis of the tumor aggravates hypoxia, acidosis and immune suppression, and leads to tumor proliferation, angiogenesis, epithelial-mesenchymal transition (EMT), invasion and metastasis. In 2017, a mechanism underlying the effects of gluconeogenesis on inhibiting glycolysis and blockading HCC progression was proposed. Treating HCC by increasing gluconeogenesis has attracted increasing attention from scientists, but few articles have summarized it. In this review, we discuss the mechanisms associated with the TME, glycolysis and gluconeogenesis and the current treatments for HCC. We believe that a treatment combination of sorafenib with TME improvement and/or anti-Warburg therapies will set the trend of advanced HCC therapy in the future.
Identifiants
pubmed: 32765096
doi: 10.2147/CMAR.S258196
pii: 258196
pmc: PMC7381782
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
5957-5974Informations de copyright
© 2020 Tian et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
J Cell Physiol. 2015 Apr;230(4):853-62
pubmed: 25204544
J Gen Physiol. 1927 Mar 7;8(6):519-30
pubmed: 19872213
Nat Rev Cancer. 2011 Aug 11;11(9):671-7
pubmed: 21833026
Autophagy. 2016 Jun 2;12(6):999-1014
pubmed: 27124102
Drug Resist Updat. 2011 Jun;14(3):191-201
pubmed: 21466972
Cell. 2015 Sep 10;162(6):1229-41
pubmed: 26321679
Blood. 2007 May 1;109(9):3812-9
pubmed: 17255361
EBioMedicine. 2019 Jan;39:239-254
pubmed: 30555042
J Hematol Oncol. 2020 Feb 7;13(1):12
pubmed: 32033570
Hepatology. 2017 Mar;65(3):789-803
pubmed: 27863447
Cancer Cell. 2015 Apr 13;27(4):450-61
pubmed: 25858804
Clin Cancer Res. 2019 Jan 15;25(2):844-855
pubmed: 30322879
Sci Rep. 2017 Jan 11;7:40446
pubmed: 28074862
J Immunol. 2016 Mar 15;196(6):2552-60
pubmed: 26873994
Cell Physiol Biochem. 2018;47(1):344-355
pubmed: 29768256
Z Krebsforsch. 1964 Feb 7;66:41-5
pubmed: 14154135
Cancer Chemother Pharmacol. 2016 May;77(5):1087-96
pubmed: 27071921
Cell. 2016 Oct 20;167(3):829-842.e13
pubmed: 27745970
Drug Resist Updat. 2015 Nov;23:69-78
pubmed: 26341193
Cell Metab. 2016 Jan 12;23(1):27-47
pubmed: 26771115
Gut. 2020 Feb;69(2):329-342
pubmed: 31439637
Mol Cancer. 2009 Jun 05;8:32
pubmed: 19497135
Nat Commun. 2018 Jan 31;9(1):446
pubmed: 29386513
Hepatology. 2020 Feb 29;:
pubmed: 32112577
Cell. 2016 Jun 30;166(1):126-39
pubmed: 27368101
Curr Med Chem. 2017;24(26):2827-2845
pubmed: 28031009
Cell Metab. 2018 Nov 6;28(5):669-670
pubmed: 30403984
Gastroenterology. 2020 Jun;158(8):2250-2265.e20
pubmed: 32060001
Front Immunol. 2018 Dec 19;9:3020
pubmed: 30619362
Int J Biol Sci. 2019 Feb 19;15(4):812-825
pubmed: 30906212
Cancer Res. 2009 Mar 15;69(6):2677-84
pubmed: 19276380
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Angiogenesis. 2011 Sep;14(3):245-53
pubmed: 21452059
Oncogene. 2011 Mar 10;30(10):1213-28
pubmed: 21057546
Oncoimmunology. 2016 Dec 7;6(1):e1264562
pubmed: 28197391
J Hepatol. 2020 Feb;72(2):320-341
pubmed: 31954495
Science. 2015 Jan 23;347(6220):400-6
pubmed: 25477212
Cell. 2018 Dec 13;175(7):1731-1743.e13
pubmed: 30503213
Nat Rev Drug Discov. 2010 Jun;9(6):447-64
pubmed: 20467424
Nat Commun. 2015 Mar 26;6:6692
pubmed: 25809635
Cell. 2010 Apr 2;141(1):39-51
pubmed: 20371344
Biochim Biophys Acta. 2015 Feb;1847(2):171-181
pubmed: 25449966
Hepatology. 2013 Jul;58(1):229-38
pubmed: 23463346
Liver Int. 2020 Jul;40(7):1756-1769
pubmed: 32174027
Toxicol Lett. 2000 Sep 30;117(1-2):95-100
pubmed: 11033238
Cancer Res. 2013 Mar 1;73(5):1524-35
pubmed: 23288510
J Hepatol. 2020 May;72(5):909-923
pubmed: 31899205
Bioorg Med Chem. 2020 Jan 15;28(2):115235
pubmed: 31843464
Acc Chem Res. 2018 Oct 16;51(10):2502-2511
pubmed: 30234960
Carcinogenesis. 2013 May;34(5):962-73
pubmed: 23358852
Mol Cancer Res. 2020 Jul;18(7):992-1003
pubmed: 32229502
Oncogene. 2015 Oct 29;34(44):5524-35
pubmed: 25684142
Biochim Biophys Acta Rev Cancer. 2019 Aug;1872(1):24-36
pubmed: 31152822
Life Sci. 2019 Dec 15;239:116966
pubmed: 31626790
FASEB J. 2005 Mar;19(3):342-53
pubmed: 15746177
Biochemistry (Mosc). 2017 Aug;82(8):861-873
pubmed: 28941454
J Exp Clin Cancer Res. 2019 Feb 15;38(1):83
pubmed: 30770740
Immunity. 2019 Feb 19;50(2):403-417.e4
pubmed: 30709740
Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1465-E1474
pubmed: 29378948
J Biol Chem. 2008 Apr 18;283(16):10892-903
pubmed: 18281291
J Exp Clin Cancer Res. 2020 Jan 30;39(1):24
pubmed: 32000827
Exp Cell Res. 2017 Jul 15;356(2):146-151
pubmed: 28456549
Cancer Res. 2016 Oct 1;76(19):5845-5856
pubmed: 27488520
Cancer Lett. 2020 Apr 28;476:140-151
pubmed: 32061951
Cell Death Dis. 2019 Apr 5;10(4):308
pubmed: 30952834
Cell. 2007 Apr 6;129(1):111-22
pubmed: 17418790
Front Immunol. 2018 May 09;9:1009
pubmed: 29867983
Nature. 2014 Sep 25;513(7519):559-63
pubmed: 25043024
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19345-50
pubmed: 18032601
Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):6042-6046
pubmed: 32111690
Hepatology. 2019 Oct;70(4):1231-1245
pubmed: 30963603
Cell Death Dis. 2020 Mar 6;11(3):174
pubmed: 32144252
Int J Biol Sci. 2019 Jul 3;15(9):1771-1786
pubmed: 31523182
Drug Discov Today. 2018 Nov;23(11):1873-1882
pubmed: 29772209
Cancer Lett. 2018 Jan 1;412:216-223
pubmed: 29074426
Cold Spring Harb Perspect Biol. 2018 Mar 1;10(3):
pubmed: 28432133
Immunity. 2016 Aug 16;45(2):358-73
pubmed: 27496729
Cancer Cell. 2018 Apr 9;33(4):649-663.e4
pubmed: 29576375
J Biol Chem. 2010 Feb 5;285(6):3651-63
pubmed: 19940151
Nat Rev Clin Oncol. 2017 Jan;14(1):11-31
pubmed: 27141887
Aging (Albany NY). 2019 Nov 20;11(22):10284-10300
pubmed: 31754081
J Biol Chem. 2012 Jan 27;287(5):3392-402
pubmed: 22170054
J Exp Clin Cancer Res. 2019 Sep 2;38(1):384
pubmed: 31477177
Oncol Rep. 2017 Jan;37(1):348-356
pubmed: 27840976
Biomaterials. 2020 Jan;228:119578
pubmed: 31678843
FASEB J. 2015 Jun;29(6):2315-26
pubmed: 25681462
Sci Signal. 2019 Dec 17;12(612):
pubmed: 31848318
Nature. 1976 Jun 24;261(5562):702-5
pubmed: 934318
World J Gastroenterol. 2016 Dec 7;22(45):9933-9943
pubmed: 28018100
Hepatology. 2019 Jul;70(1):168-183
pubmed: 30411378
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Cell Metab. 2016 Nov 8;24(5):657-671
pubmed: 27641098
Br J Cancer. 2013 Jan 15;108(1):72-81
pubmed: 23257894
J Biol Chem. 2008 Oct 17;283(42):28106-14
pubmed: 18718909
Cell Death Dis. 2019 Dec 9;10(12):934
pubmed: 31819034
Nat Rev Clin Oncol. 2017 Dec;14(12):717-734
pubmed: 28741618
Oncogene. 2020 Apr;39(16):3229-3244
pubmed: 32071398
Sci Rep. 2020 Apr 28;10(1):7139
pubmed: 32345994
Cancer Lett. 2019 Jul 10;454:215-223
pubmed: 30980867
ChemMedChem. 2018 Nov 6;13(21):2251-2265
pubmed: 30226288
J Clin Invest. 2008 Dec;118(12):3930-42
pubmed: 19033663
Front Immunol. 2019 Aug 27;10:1889
pubmed: 31507585
J Exp Clin Cancer Res. 2019 Feb 4;38(1):50
pubmed: 30717766
J Exp Clin Cancer Res. 2019 Mar 25;38(1):136
pubmed: 30909929
J Biol Chem. 2016 Sep 16;291(38):20188-97
pubmed: 27510037
Gastroenterology. 2020 Feb;158(3):664-678.e24
pubmed: 31678303
J Hepatol. 2019 May;70(5):999-1007
pubmed: 30738077
Elife. 2016 Aug 02;5:
pubmed: 27481188
Clin Cancer Res. 2018 Jan 15;24(2):474-485
pubmed: 29084919
Oncol Lett. 2019 Dec;18(6):5663-5672
pubmed: 31788038
Cancer Res. 2020 Feb 15;80(4):657-658
pubmed: 32060227
Mol Oncol. 2019 May;13(5):1311-1331
pubmed: 30959553
Nat Commun. 2019 May 13;10(1):2130
pubmed: 31086178
Nat Commun. 2019 Oct 17;10(1):4720
pubmed: 31624249
Cancer Res. 2011 Apr 1;71(7):2550-60
pubmed: 21300765
Front Immunol. 2017 Mar 08;8:248
pubmed: 28337200
Clin Nucl Med. 2018 Jan;43(1):31-32
pubmed: 29112010
Cancer Metab. 2015 Aug 26;3:8
pubmed: 26322231
Nat Rev Drug Discov. 2008 Feb;7(2):168-81
pubmed: 18167490
Nat Commun. 2020 Feb 5;11(1):708
pubmed: 32024842
Elife. 2019 Jul 01;8:
pubmed: 31259690
J Biomed Sci. 2016 Oct 4;23(1):69
pubmed: 27716281
Mol Cancer. 2019 Nov 11;18(1):157
pubmed: 31711497
Cell Metab. 2011 Jul 6;14(1):91-103
pubmed: 21723507
Cancer Res. 2017 Nov 15;77(22):6375-6388
pubmed: 28883004
Gastroenterology. 2019 May;156(6):1877-1889.e4
pubmed: 30710528
Clin Cancer Res. 2020 Jan 15;26(2):428-438
pubmed: 31582517
Cancer Lett. 2017 Mar 1;388:54-63
pubmed: 27913198
Cell Death Dis. 2020 Feb 4;11(2):91
pubmed: 32019910
Nat Commun. 2014 Sep 25;5:4900
pubmed: 25254627
Science. 2014 Sep 26;345(6204):1250684
pubmed: 25258083
Trends Endocrinol Metab. 2015 Dec;26(12):699-710
pubmed: 26520657
Cell Metab. 2006 Mar;3(3):187-97
pubmed: 16517406
Mol Cells. 2015 Jun;38(6):528-34
pubmed: 26013382
Angew Chem Int Ed Engl. 2019 Nov 25;58(48):17158-17162
pubmed: 31591797
Am J Cancer Res. 2020 Jan 01;10(1):60-77
pubmed: 32064153
Nat Immunol. 2018 Jul;19(7):723-732
pubmed: 29915296
Sci Rep. 2017 Oct 2;7(1):12486
pubmed: 28970582
Expert Opin Drug Discov. 2019 Jul;14(7):667-682
pubmed: 31070059
Proc Natl Acad Sci U S A. 2020 Mar 10;117(10):5402-5408
pubmed: 32102913
Hepatology. 2020 Feb 16;:
pubmed: 32064645
Autophagy. 2019 Jul;15(7):1258-1279
pubmed: 30786811
Curr Opin Genet Dev. 2009 Feb;19(1):60-6
pubmed: 19167211
Stem Cells Dev. 2018 Jul 1;27(13):935-947
pubmed: 29717634
Nature. 2019 Dec;576(7787):465-470
pubmed: 31827286
Cell. 2016 Jun 30;166(1):63-76
pubmed: 27293185
Br J Cancer. 2020 Jan;122(2):209-220
pubmed: 31819189
Biomed Pharmacother. 2019 Mar;111:1353-1358
pubmed: 30841449
Immunity. 2019 Apr 16;50(4):924-940
pubmed: 30995507
Cancer Lett. 2019 Oct 28;463:11-26
pubmed: 31404613
J Cell Biol. 2017 Mar 6;216(3):723-741
pubmed: 28183717
Nature. 2016 Mar 10;531(7593):253-7
pubmed: 26934227
Nat Commun. 2017 Nov 17;8(1):1597
pubmed: 29150606
Transl Oncol. 2020 Aug;13(8):100785
pubmed: 32416440
Cancer Res. 2016 Jun 1;76(11):3265-76
pubmed: 27197151
Int J Mol Sci. 2016 Dec 28;18(1):
pubmed: 28036048
Int J Oncol. 2017 May;50(5):1848-1856
pubmed: 28393220
Cell. 2013 Jun 6;153(6):1239-51
pubmed: 23746840
J Immunother Cancer. 2019 Jun 13;7(1):151
pubmed: 31196176
Cancer. 2016 Feb 1;122(3):367-77
pubmed: 26540029
Front Pharmacol. 2017 Oct 18;8:730
pubmed: 29093678
Liver Int. 2020 May;40(5):1211-1223
pubmed: 32077551
Nature. 2009 Jul 2;460(7251):103-7
pubmed: 19494812
Cancer Chemother Pharmacol. 2017 Nov;80(5):925-937
pubmed: 28861639
Nat Rev Immunol. 2018 May;18(5):340-356
pubmed: 29379213
Cell Metab. 2014 Jul 1;20(1):61-72
pubmed: 24930970
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8847-51
pubmed: 9671767
Magn Reson Med. 2020 May;83(5):1553-1564
pubmed: 31691371
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):E7240-E7249
pubmed: 27799536
Nat Commun. 2019 Apr 23;10(1):1909
pubmed: 31015417
Science. 2018 Jan 12;359(6372):177-186
pubmed: 29326266
Nat Chem Biol. 2016 Oct;12(10):779-86
pubmed: 27479743
Nat Commun. 2017 Feb 27;8:14420
pubmed: 28240261
Cancer Immunol Res. 2019 Sep;7(9):1535-1546
pubmed: 31311791
Cancer Res. 2020 Feb 15;80(4):675-688
pubmed: 31948940
Ernst Schering Found Symp Proc. 2007;(4):35-53
pubmed: 18811052
Nat Commun. 2016 Aug 03;7:12431
pubmed: 27485204
Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):E6546-E6555
pubmed: 29941600
Redox Biol. 2017 Aug;12:208-215
pubmed: 28259101
Sci Rep. 2017 Mar 06;7:43864
pubmed: 28262837
Nat Commun. 2018 Aug 17;9(1):3303
pubmed: 30120232
Cell Prolif. 2019 May;52(3):e12581
pubmed: 30895661
Oncoimmunology. 2018 Mar 26;7(7):e1445452
pubmed: 29900055
Nat Rev Immunol. 2005 Nov;5(11):844-52
pubmed: 16239903
Oncogene. 2019 Feb;38(8):1239-1255
pubmed: 30250300
Nat Commun. 2018 Aug 24;9(1):3430
pubmed: 30143633
Mol Cancer. 2018 Mar 14;17(1):73
pubmed: 29540185
Cell Death Dis. 2019 Oct 3;10(10):742
pubmed: 31582735
Cell Death Dis. 2020 May 7;11(5):332
pubmed: 32382077
Hepatology. 2019 Apr;69(4):1768-1786
pubmed: 30561826
Oncogene. 2018 Mar;37(12):1637-1653
pubmed: 29335519
Nat Commun. 2018 Jan 16;9(1):249
pubmed: 29339767
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Cancer Res. 2019 Aug 15;79(16):4160-4172
pubmed: 31266773
Aging (Albany NY). 2020 Feb 21;12(4):3431-3450
pubmed: 32084009
Cell Oncol (Dordr). 2020 Feb;43(1):137-153
pubmed: 31691159
Cells. 2020 Jan 14;9(1):
pubmed: 31947613
Cancer Lett. 2015 Jan 28;356(2 Pt A):156-64
pubmed: 24732809
Mol Aspects Med. 2015 Dec;46:21-33
pubmed: 26549348
Immunity. 2016 Aug 16;45(2):374-88
pubmed: 27496732
J Clin Invest. 2013 Oct;123(10):4479-88
pubmed: 24091329
Drug Des Devel Ther. 2019 Jul 04;13:2215-2234
pubmed: 31308633
Cancer Lett. 2017 Aug 1;400:89-98
pubmed: 28461244
Int J Mol Sci. 2019 Aug 19;20(16):
pubmed: 31430957
Trends Immunol. 2015 Feb;36(2):63-70
pubmed: 25582039
Science. 2012 Aug 24;337(6097):975-80
pubmed: 22923583
Science. 2016 Dec 2;354(6316):1160-1165
pubmed: 27789795
Dis Model Mech. 2011 Nov;4(6):727-32
pubmed: 22065843
Theranostics. 2018 Sep 09;8(17):4649-4663
pubmed: 30279729
FASEB J. 2020 Apr;34(4):5420-5434
pubmed: 32080912
BMC Res Notes. 2013 Jul 17;6:277
pubmed: 23866825
J Hepatol. 2013 Jul;59(1):81-8
pubmed: 23466307
J Exp Clin Cancer Res. 2018 Jun 4;37(1):113
pubmed: 29866133
Cell. 2019 Apr 4;177(2):414-427.e13
pubmed: 30951669
J Exp Clin Cancer Res. 2018 Sep 4;37(1):216
pubmed: 30180863
Inflamm Res. 2018 Oct;67(10):813-828
pubmed: 30066126
Autophagy. 2012 Aug;8(8):1264-6
pubmed: 22660171
Front Oncol. 2019 Nov 18;9:1248
pubmed: 31803621
Nature. 2019 Jan;565(7740):495-499
pubmed: 30626970
Cell Metab. 2011 Dec 7;14(6):768-79
pubmed: 22100406